Mercilon

Desogestrel/Ethinylestradiol, the active ingredients in Mercilon, are a combined oral contraceptive presented as an oral tablet for oral use. It is indicated for prevention of pregnancy and may be used to regulate menstrual cycles in women of reproductive age.

GNH USA supplies Mercilon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mercilon is a combined hormonal contraceptive that acts on the hypothalamic‑pituitary‑ovarian axis to prevent pregnancy and manage menstrual disorders. - Contraception: prevents pregnancy by suppressing ovulation and altering cervical mucus. - Menstrual cycle regulation: provides more predictable bleeding patterns and reduces dysmenorrhea. - Acne improvement (off‑label): may lessen androgen‑related acne in some women.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: occasional tension‑type headache. - Breakthrough bleeding: spotting between periods. - Mood changes: mild emotional fluctuations. - Weight gain: slight increase in body weight.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Arterial thrombosis: clot formation in arteries, leading to stroke or heart attack. - Hypertension: significant rise in blood pressure. - Liver tumor: benign hepatic adenoma. - Gallbladder disease: formation of gallstones. - Severe allergic reaction: anaphylaxis or angioedema.

Before starting Mercilon, consider the following precautions. - Contraindicated in women with a history of thromboembolic disorders: avoid use. - Do not use if pregnant: discontinue immediately. - Smoking over 15 cigarettes per day: increased cardiovascular risk. - Monitor blood pressure regularly: risk of hypertension. - Review concurrent medications: see interaction section. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Mercilon may interact with several medicines, affecting its efficacy or safety. Major Interactions (Avoid): - Enzyme‑inducing antiepileptics (e.g., carbamazepine, phenytoin): markedly reduce hormonal levels. - Rifampin: decreases contraceptive effectiveness. Moderate Interactions (Monitor Closely): - Broad‑spectrum antibiotics (e.g., ampicillin): may slightly lower efficacy. - Azole antifungals (e.g., fluconazole): can increase hormone concentrations. - Selective serotonin reuptake inhibitors (e.g., fluoxetine): may raise bleeding risk.